Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/12/2005CN1679539A Synergic medicinal composition for preventing from tumor
10/12/2005CN1679538A Oral preparation of diterpene compounds against cancers and preparing method and use thereof
10/12/2005CN1679537A Single nitrate isosorbide sodium chloride injection
10/12/2005CN1679536A Single nitrate isosorbide delayed-release tablets
10/12/2005CN1679534A 持久力改善剂 Endurance improving agent
10/12/2005CN1679533A Levo carnitine dropping pill and preparation thereof
10/12/2005CN1679532A Therapeutic and dietary compositions
10/12/2005CN1679531A N(2)-L-alanyl-L-glutamine aseptic powdery preparation and process for prepairing same
10/12/2005CN1679530A 布洛芬乳剂 Ibuprofen cream
10/12/2005CN1679529A Chinese medicinal hypoglycemic agent and preparation thereof
10/12/2005CN1679528A Danshensu and its sodium salt for preventing from and treating various regressive nervous diseases
10/12/2005CN1679527A Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
10/12/2005CN1679526A External-applied medicine for treating achromoderma and production thereof
10/12/2005CN1679525A Oral disintegrant of compound paracetamol
10/12/2005CN1679524A Gum of ambroxol hydrochloride and preparation thereof
10/12/2005CN1679523A Analgesic injecting powder preparation and preparation thereof
10/12/2005CN1679522A Composition of an external dermatological agent
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1679519A Ginkgo keto-ester soft capsules with long stable effect and preparation thereof
10/12/2005CN1679514A Liposome and lipid composite preparation of nucleoside phosphoric acid compound
10/12/2005CN1679472A Antimycotic nail varnish composition
10/12/2005CN1679406A Compound with vitamin k activity, particularly as additive for feeds, and preparation of the compound
10/12/2005CN1679403A Fat or oil composition
10/12/2005CN1222534C Form VI5, 6-dichloro-2-(isopropylamino)-1-(&beta-L-ribofuranosyl)-1H-benzimidazole
10/12/2005CN1222533C Gallotannins and ellagitannins as regulators of cytokine release
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222526C Chlorophyll and bacteriochlorophyll esters, and their preparation
10/12/2005CN1222525C Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
10/12/2005CN1222524C Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
10/12/2005CN1222521C Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222517C Method for preparing xitaipulan
10/12/2005CN1222514C Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/12/2005CN1222510C Novel benzoylguanidine salt
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222321C Pharmaceutical compositions containing cyclodextrins and taxoids
10/12/2005CN1222320C Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof
10/12/2005CN1222319C Composition for IVF
10/12/2005CN1222316C Oral liquor composition with reduced bitter taste
10/12/2005CN1222300C Detoxicating and skin-growing ointment for treating burn
10/12/2005CN1222299C Detoxicating and skin-growing powder for treating burn
10/12/2005CN1222298C Medicine for treating cardiovascular disease
10/12/2005CN1222297C Combined cartilage and plant extract composition
10/12/2005CN1222295C Neutrophil leucocyte functional inhibitor
10/12/2005CN1222294C Combined preparations comprising morpholine anthracyclines and anticancer agent
10/12/2005CN1222293C NKT cell activators contg. alpha-glycosylceramides
10/12/2005CN1222292C Fulvestrant formulation
10/12/2005CN1222291C Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor
10/12/2005CN1222290C Novel composition and use thereof
10/12/2005CN1222289C Application of insulin sensitizer and medicament
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222287C Pharmaceutical formulations contg. zolmitriptan
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/12/2005CN1222285C Rebescensine A emulsion and its preparing method
10/12/2005CN1222284C High lipid diet
10/12/2005CN1222283C Methods of rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
10/12/2005CN1222282C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide
10/12/2005CN1222280C Topical plaster with non-steroidal antirheumatic agents with an acid group
10/12/2005CN1222279C Prolonged release bioadhesive vaginal gel dosage form
10/12/2005CN1222278C Alpha-linolenic acid microcapsule and its preparing process
10/12/2005CN1222277C Microgranules based on active principle and method for making same
10/12/2005CN1222276C Albendazole lipid and method for preparing said lipid by neutralization method
10/11/2005US6953865 reacting (R)- or (S)- nitryloxycarnitine with sodium azide; hydrogenation to the intermediate azidocarnitine of same configuration; no isolation
10/11/2005US6953861 Method of re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953851 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
10/11/2005US6953813 2-Aminotetralin derivatives for the therapy of glaucoma
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953808 Method for treating gastric disorders using optically pure (−) pantoprazole
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953805 Ethyl 6-(((2S)-2-(Ethoxycarbonyl)-4,4-difluoropyrrolidinyl)methyl)-1,2,3,4,4a, 5,6,7,8,8a-decahydroisoquinoline-3-carboxylate, treating migraine pain without attending side effects
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953800 Quinazoline derivatives
10/11/2005US6953799 which buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953794 Monitoring treatment for nervous system didorders; obtain cell sample containing tau protein, incubate with modulator, monitor tau binding, adjustment in tau binding indicates modulators
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953790 CGRP receptor antagonists
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953786 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
10/11/2005US6953782 antibacterial; substituted methylene in the 11 position
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953776 Ophthalmic formulations
1 ... 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 ... 7860